US$ 24.04
list of glp-1 agonists Clinical Trials Evaluating the Cardiovascular Efficacy and List of current GLP-1 and
Description
38 Grauslund et al identified all patients with diabetes in Denmarks national health registry and found that semaglutide was an independent predictor of incident NAION (HR = 2.19)

Because some of the same brain and body systems that regulate appetite also influence reward and craving, researchers are now asking whether these medications could also help people reduce alcohol and other substance use

www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014

The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimers disease
& Lu, J

What monitoring is needed when taking GLP-1 agonists with a lymphoproliferative disorder